Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Endeavor Biomedicines, Inc.
Fusion Pharmaceuticals Inc.
Novelty Nobility, Inc.
Provectus Pharmaceuticals
Yale University
Delcath Systems Inc.
National Institutes of Health Clinical Center (CC)